يكون مالك
العرض فقط
تحميل وتحرير
يمكن للأعضاء فقط عرض العناصر في هذا المجلد.
يمكن للأعضاء عرض، إضافة وتعديل وحذف العناصر الموجودة في هذا المجلد.

4shared الخاص بي

278,974 KB • 99 ملفات

إبلاغ عن إساءة الاستخدام
التنزيل بوصفه مضغوط
إضافة إلى حسابي
 
الاسم الحجم تاريخ الإضافة أضف الى حساب
shared
shared
A closer look at new FDA actions- INTELENCE.pdf
A closer look at new FDA actions- INTELENCE.pdf
A novel approach for analyzing glass-transition temperature vs. composition patterns- Application to pharmaceutical compound + polymer systems.pdf
A novel approach for analyzing glass-transition temperature vs. composition patterns- Application to pharmaceutical compound + polymer systems.pdf
A REVIEW ON PATHOLOGY OF AIDS AND ITS TREATMENT REGIMENS.pdf
A REVIEW ON PATHOLOGY OF AIDS AND ITS TREATMENT REGIMENS.pdf
additional antiretroviral.pdf
additional antiretroviral.pdf
amorphous pharmaceutical solids- preparation, characterization.pdf
amorphous pharmaceutical solids- preparation, characterization.pdf
an improved kinetics approach to describe the physical stability of amorphous.pdf
an improved kinetics approach to describe the physical stability of amorphous.pdf
An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.pdf
An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.pdf
antiviral drugs basic discovery.pdf
antiviral drugs basic discovery.pdf
Assessment of the steady-state pharmacokinetic.pdf
Assessment of the steady-state pharmacokinetic.pdf
ATOMIZ_1.PDF
ATOMIZ_1.PDF
atomization for spray drying- unanswered questions and industrial needs.pdf
atomization for spray drying- unanswered questions and industrial needs.pdf
BASF.pdf
BASF.pdf
BETE_SprayDryManual.pdf
BETE_SprayDryManual.pdf
clinical pharmacokinetics and pharmacodynamics of etravieine.pdf
clinical pharmacokinetics and pharmacodynamics of etravieine.pdf
clinical pharmacokinetics and pharmacodynamics of etravirine.pdf
clinical pharmacokinetics and pharmacodynamics of etravirine.pdf
clinical pharmacokinetics and pharmacodynamics.pdf
clinical pharmacokinetics and pharmacodynamics.pdf
combinatorial approaches to the prevention and treatment.pdf
combinatorial approaches to the prevention and treatment.pdf
comparison of hpmc based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.pdf
comparison of hpmc based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.pdf
Copy of Modern Pharmaceutics, Fifth Edition, Volume 2 Applications and Advances.pdf
Copy of Modern Pharmaceutics, Fifth Edition, Volume 2 Applications and Advances.pdf
design strategies of novel NNRTI to overcome drug resistance.pdf
design strategies of novel NNRTI to overcome drug resistance.pdf
Differences in the physical state and thermal behavior of spray-dried and freeze-dried lactose and lactose or protein mixtures.pdf
Differences in the physical state and thermal behavior of spray-dried and freeze-dried lactose and lactose or protein mixtures.pdf
dissolution enhancement of a poorly water-soluble antimalarial drug by means of a modified multi-fluid nozzle pilot spray drier.pdf
dissolution enhancement of a poorly water-soluble antimalarial drug by means of a modified multi-fluid nozzle pilot spray drier.pdf
dose contraindications warnings of etravirine.pdf
dose contraindications warnings of etravirine.pdf
drug delivery systems in hiv pharmacotherapy= what has been done and the challenges standing ahead.pdf
drug delivery systems in hiv pharmacotherapy= what has been done and the challenges standing ahead.pdf
Drug-resistant human immunodefiency virus.pdf
Drug-resistant human immunodefiency virus.pdf
duet studies sing praises of etravirine.pdf
duet studies sing praises of etravirine.pdf
dynamics of cancer.pdf
dynamics of cancer.pdf
endothelial inflammatory coagulaton metabolic effects and safety of etravirine in hiv infected volunteers.pdf
endothelial inflammatory coagulaton metabolic effects and safety of etravirine in hiv infected volunteers.pdf
Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.pdf
Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.pdf

الاطلاع على29 office ملف على المجلد الخاص بي 4shared الخاص بي على 4shared

شروط الاستخدام
الخصوصية
الدعم
Do not sell my personal information
Do not share my personal information
Mobile Version
• العربية
Deutsch
Русский
한국어
Bahasa Indonesia
Bahasa Melayu
Português (Brasil)
English
Italiano
Français
Español
中文
Tiếng Việt
ไทย
日本語
پارسی
Polski
Türkçe
We Use Cookies. 4shared uses cookies and other tracking technologies to understand where our visitors are coming from and improve your browsing experience on our Website. By using our Website, you consent to our use of cookies and other tracking technologies. Change my preferences
I Agree